openPR Logo
Press release

Neurological Biomarkers Market Set to Surge to $18.34 Billion by 2031, Growing at a 12.78% CAGR, According to TLM Research

09-04-2024 11:42 AM CET | Health & Medicine

Press release from: The Lifesciences Magazine

Neurological Biomarkers Market

Neurological Biomarkers Market

Neurological Biomarkers Market 2024-2031 Forecast: Unveiling Opportunities and Growth

Global Neurological Biomarkers Market is an exploration report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. These bits of knowledge offered in the Neurological Biomarkers Market report would benefit request players to define systems for the future and gain a solid situation in the worldwide market request development. Other than this, the specialists have profoundly contemplated distinctive geological regions and introduced a serious situation to help new rivals, driving business sector players and fiscal backers to decide arising economies.

According to TLM Research, the Neurological Biomarkers Market size is estimated to increase by USD 18.34 Billion at a CAGR of 12.78% from 2024 to 2031. Currently, the market value is pegged at USD 9.02 Billion.

Get a Sample PDF of the report @ https://thelifesciencesmagazine.com/request-sample/neurological-biomarkers-market/

Key Players in the Neurological Biomarkers market:
PerkinElmer, Inc,
Bio-Rad Laboratories, Inc,
MYRIAD RBM, Neurobio,
Baxter International,
F. HOFFMANN-LA ROCHE LTD,
Thermo Fisher Scientific, Inc.,
Quanterix, bioMérieux,
Merck KGAA

Market Leaders & Development Strategies:

Bio-Rad Laboratories, Inc: In January 2024, Bio-Rad announced the launch of its QX200 Droplet Digital PCR System, a compact and affordable system for high-throughput and precise gene expression analysis.

MYRIAD RBM: In September 2023, Myriad RBM acquired Counsyl, a leader in non-invasive prenatal testing (NIPT), expanding their offerings in women's health and prenatal care.

Market Drivers:
Technological Advancements in Diagnostic Tools
Advancements in Biomarker Discovery Technologies
Increasing Incidence of Neurological Disorders

Market Restraints:
Ethical and Privacy Concerns
Lack of Standardization and Validation

Market Opportunities:
Increasing Research in Neuroscience
Integration of Biomarkers into Clinical Trials

Get a Discount on Research Report @ https://thelifesciencesmagazine.com/request-discount/neurological-biomarkers-market/

Market Segmentation & Coverage:

This research report categorizes the Neurological Biomarkers Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based On Type of Biomarker: The market is segmented into Proteomic Biomarkers, Genomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers. Among these the Imaging Biomarkers is major revenue contributor.

Based On Type: The market is segmented into Reagents and Kits, Assay Kits, Instruments and Software. Among these Reagents and Kits hold the largest revenue share.

Based On Application: Based on Application segmentation, the market is further divided into Alzheimer's disease Biomarkers, Parkinson's disease Biomarkers, Multiple Sclerosis Biomarkers, Other Neurological Disorders. Among these, the Alzheimer's Disease Biomarkers hold the larger revenue share.

Based On End-User: Based on End-User segmentation, the market is further divided into Hospitals and Clinics, Diagnostic Laboratories, and Research Institutes. Among these, the Hospitals & Clinics contributes largest revenue share.

Neurological Biomarkers Market Regional Analysis:

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Neurological Biomarkers in these regions, covering

North America (USA, Canada and Mexico)
Europe (UK, Germany, France and the Rest of Europe)
Asia Pacific (China, Japan, India, and the Rest of the Asia Pacific region)
South America (Brazil, Argentina and the Rest of South America)
Middle East and Africa (GCC and Rest of the Middle East and Africa)

** Note - This report sample includes:

Scope For 2025
Brief Introduction to the research report.
Table of Contents (Scope covered as a part of the study)
Top players in the market
Research framework (structure of the report)
Research methodology adopted by TLM Research

Request for Pre-Order Inquiry @ https://thelifesciencesmagazine.com/pre-order-inquiry/neurological-biomarkers-market/

FIVE FORCES & PESTLE ANALYSIS:

In order to better understand market conditions five forces analysis is conducted that includes the Bargaining power of buyers, Bargaining power of suppliers, Threat of new entrants, Threat of substitutes, and Threat of rivalry.

• Political (Political policy and stability as well as trade, fiscal, and taxation policies)

• Economical (Interest rates, employment or unemployment rates, raw material costs, and foreign exchange rates)

• Social (Changing family demographics, education levels, cultural trends, attitude changes, and changes in lifestyles)

• Technological (Changes in digital or mobile technology, automation, research, and development)

• Legal (Employment legislation, consumer law, health, and safety, international as well as trade regulation and restrictions)

•Environmental (Climate, recycling procedures, carbon footprint, waste disposal, and sustainability)

Key takeaways from the Neurological Biomarkers Market report:

• Detailed consideration of Neurological Biomarkers industry-particular drivers, Trends, constraints, Restraints, Opportunities, and major micro markets.

• In-depth study of industry strategies for growth of the Neurological Biomarkers market-leading players.

• Neurological Biomarkers market latest innovations and major procedures.

• Favourable dip inside Vigorous high-tech and market latest trends remarkable the Market.

• Conclusive study about the growth conspiracy of Neurological Biomarkers market for forthcoming years.

Contact:
Matthew Eden
matthew@thelifesciencesmagazine.com
+1 (408) 520-9503
Website- https://thelifesciencesmagazine.com/

About Us:
The Lifesciences Magazine is a global healthcare solutions platform that paves the way for various healthcare innovations, expert advice, and the success stories of professionals in the field who are driving transformation with their innovative thinking.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurological Biomarkers Market Set to Surge to $18.34 Billion by 2031, Growing at a 12.78% CAGR, According to TLM Research here

News-ID: 3644978 • Views:

More Releases from The Lifesciences Magazine

Medical Billing Outsourcing Market Set to Surge to $28.5 Billion by 2031, Growing at a 12.26% CAGR, According to TLM Research
Medical Billing Outsourcing Market Set to Surge to $28.5 Billion by 2031, Growin …
Medical Billing Outsourcing Market 2024-2031 Forecast: Unveiling Opportunities and Growth Global Medical Billing Outsourcing Market is an exploration report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. These bits of knowledge offered in the Medical Billing Outsourcing Market report would benefit request players to define systems for the future
Healthcare Payer Analytics Market Set to Surge to $23.7 Billion by 2031, Growing at a 21.9% CAGR, According to Stellar Market Research
Healthcare Payer Analytics Market Set to Surge to $23.7 Billion by 2031, Growing …
Healthcare Payer Analytics Market 2024-2031 Forecast: Unveiling Opportunities and Growth Global Healthcare Payer Analytics Market is an exploration report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. These bits of knowledge offered in the Healthcare Payer Analytics Market report would benefit request players to define systems for the future
Healthcare Navigation Platform Market to Grow from USD 10.82 Billion in 2023 to USD 11.3 Billion by 2031, Achieving a CAGR of 8.49%
Healthcare Navigation Platform Market to Grow from USD 10.82 Billion in 2023 to …
Healthcare Navigation Platform Market 2024-2031 Forecast: Unveiling Opportunities and Growth Global Healthcare Navigation Platform Market is an exploration report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. These bits of knowledge offered in the Healthcare Navigation Platform Market report would benefit request players to define systems for the future
Healthcare Workforce Management System Market is Poised to Grow a Robust CAGR of 13.2% by 2031
Healthcare Workforce Management System Market is Poised to Grow a Robust CAGR of …
Healthcare Workforce Management System Market 2024-2031 Forecast: Unveiling Opportunities and Growth Global Healthcare Workforce Management System Market is an exploration report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. These bits of knowledge offered in the Healthcare Workforce Management System Market report would benefit request players to define systems

All 5 Releases


More Releases for Biomarker

Transformative Trends Impacting the Multiplex Biomarker Imaging Market Landscape …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Multiplex Biomarker Imaging Market Size By 2025? In recent times, the size of the multiplex biomarker imaging market has experienced significant growth. There is an expected rise from $0.49 billion in 2024 to $0.54 billion in 2025, with a compound annual growth rate (CAGR) of
Blood-Based Biomarker Market Beyond the Needle: The Future of Diagnostics Lies i …
Blood-Based Biomarker Market worth $51.71 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Blood-Based Biomarker Market - (By Type (Screening Biomarker, Diagnosis Biomarker, Others), By Disease (Cancer, Neurological Disorders, Others), By Application (Diagnostics, Drug Discovery, Personalized Medicine)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic,
Biomarker Discovery Outsourcing Services Market Biomarker Discovery Outsourcing: …
Biomarker Discovery Outsourcing Services Market to reach over USD 52.82 billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers And Surrogate Endpoints), Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases), Discovery Phase (Biomarker Identification, Biomarker Validation,
Biomarker and Companion Diagnostics Conference | Modeling Strategies for Biomark …
MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 20-21 June 2024 in Boston, USA. Register Now @ https://events.marketsandmarkets.com/2nd-annual-biomarker-and-companion-diagnostics-conference-usa-edition/register MarketsandMarkets 5th Annual Biomarker and Companion Diagnostics Conference: Immerse yourself in the realm of biomarkers at our flagship event, where industry leaders and experts converge to propel innovation in healthcare, diagnostics, and personalized medicine. This conference serves as a dynamic platform for collaboration, knowledge sharing, and exploration of cutting-edge
Central Nervous System (CNS) Biomarkers Market Analysis Forecast 2023-2028 Globa …
The Central Nervous System (CNS) biomarkers market refers to the market for biomarkers used in the diagnosis, prognosis, and monitoring of diseases and disorders affecting the central nervous system. The central nervous system includes the brain and spinal cord, and disorders affecting this system can have significant impacts on an individual's health and well-being. CNS biomarkers are measurable indicators that can provide information about the state of the central nervous system,
Multiplex Biomarker Imaging Market - Advanced Solutions for Comprehensive Biomar …
Newark, New Castle, USA: The "Multiplex Biomarker Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Multiplex Biomarker Imaging Market: https://www.growthplusreports.com/report/multiplex-biomarker-imaging-market/8558 This latest report researches the industry structure,